XSHE300358
Market cap510mUSD
Jan 10, Last price
6.34CNY
1D
-3.65%
1Q
-12.91%
Jan 2017
-63.23%
IPO
-39.79%
Name
Truking Technology Ltd
Chart & Performance
Profile
Truking Technology Limited engages in the research and development of pharmaceutical and medical equipment in China. The company offers solutions for sterile products lyophilization, ampoule injectable products, vial injectable products, vial(powder) products, pre-filling and sealing products, plastic bottle blow-fill-seal, cartridge, non-PVC soft bag, and glass infusion bottle production, as well as fluid processing systems. It also offers isolating systems and lyophilization laboratory. The company exports its products to approximately 40 countries and regions in Asia, Europe, South America, and internationally. Truking Technology Limited was founded in 2000 and is headquartered in Changsha, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 6,804,181 5.56% | 6,445,551 22.54% | |||||||
Cost of revenue | 5,769,094 | 5,555,457 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 1,035,088 | 890,094 | |||||||
NOPBT Margin | 15.21% | 13.81% | |||||||
Operating Taxes | (6,308) | 13,492 | |||||||
Tax Rate | 1.52% | ||||||||
NOPAT | 1,041,396 | 876,602 | |||||||
Net income | 317,076 -44.12% | 567,448 0.18% | |||||||
Dividends | (89,124) | (69,075) | |||||||
Dividend yield | 1.43% | 0.80% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 621,154 | 266,700 | |||||||
Long-term debt | 135,471 | 296,643 | |||||||
Deferred revenue | 63,838 | 169,895 | |||||||
Other long-term liabilities | 382,579 | 173,651 | |||||||
Net debt | (137,202) | (578,162) | |||||||
Cash flow | |||||||||
Cash from operating activities | 205,190 | 24,799 | |||||||
CAPEX | (617,461) | ||||||||
Cash from investing activities | (655,072) | ||||||||
Cash from financing activities | 195,840 | 86,118 | |||||||
FCF | 13,538 | 387,846 | |||||||
Balance | |||||||||
Cash | 807,247 | 1,141,505 | |||||||
Long term investments | 86,579 | ||||||||
Excess cash | 553,618 | 819,227 | |||||||
Stockholders' equity | 2,684,475 | 2,776,508 | |||||||
Invested Capital | 5,331,227 | 4,215,294 | |||||||
ROIC | 21.82% | 24.91% | |||||||
ROCE | 17.02% | 17.04% | |||||||
EV | |||||||||
Common stock shares outstanding | 581,044 | 584,697 | |||||||
Price | 10.69 -27.53% | 14.75 -43.42% | |||||||
Market cap | 6,211,361 -27.98% | 8,624,279 -41.27% | |||||||
EV | 6,113,281 | 8,128,302 | |||||||
EBITDA | 1,280,233 | 1,090,101 | |||||||
EV/EBITDA | 4.78 | 7.46 | |||||||
Interest | 35,517 | 16,850 | |||||||
Interest/NOPBT | 3.43% | 1.89% |